Total Payments
$160,111
2024 Payments
$437.15
Companies
34
Transactions
584
Medicare Patients
933
Medicare Billing
$101,853
Payment Breakdown by Category
Other$134,428 (84.0%)
Food & Beverage$16,892 (10.6%)
Travel$8,763 (5.5%)
Education$27.65 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,428 | 55 | 84.0% |
| Food and Beverage | $16,892 | 479 | 10.6% |
| Travel and Lodging | $8,763 | 48 | 5.5% |
| Education | $27.65 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $80,197 | 196 | $0 (2024) |
| Shire North American Group Inc | $47,061 | 86 | $0 (2019) |
| Mylan Specialty L.P. | $17,813 | 29 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,914 | 30 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $2,344 | 61 | $0 (2024) |
| ALK-Abello, Inc | $1,421 | 6 | $0 (2018) |
| GENZYME CORPORATION | $1,178 | 34 | $0 (2024) |
| Octapharma USA, Inc. | $796.63 | 18 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $535.05 | 20 | $0 (2023) |
| ViiV Healthcare Company | $492.26 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $437.15 | 7 | AstraZeneca Pharmaceuticals LP ($251.83) |
| 2023 | $47,969 | 88 | GlaxoSmithKline, LLC. ($46,702) |
| 2022 | $12,987 | 84 | GlaxoSmithKline, LLC. ($11,039) |
| 2021 | $20,102 | 67 | GlaxoSmithKline, LLC. ($16,745) |
| 2020 | $6,440 | 53 | GlaxoSmithKline, LLC. ($3,897) |
| 2019 | $5,043 | 67 | Shire North American Group Inc ($2,964) |
| 2018 | $25,702 | 94 | Shire North American Group Inc ($22,696) |
| 2017 | $41,429 | 124 | Shire North American Group Inc ($21,400) |
All Payment Transactions
584 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Immunology | ||||||
| 10/17/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Inflammation & Immunology | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Immunology | ||||||
| 08/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $101.65 | General |
| Category: Respiratory | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $115.94 | General |
| 04/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $46.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $57.23 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $553.00 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $810.00 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $106.33 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $217.00 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $796.51 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $415.13 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $8.00 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $8.00 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $183.68 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 125 | 308 | $31,960 | $12,799 |
| 2022 | 13 | 318 | 889 | $96,786 | $36,108 |
| 2021 | 8 | 255 | 656 | $77,480 | $28,008 |
| 2020 | 8 | 235 | 633 | $70,735 | $24,938 |
Total Patients
933
Total Services
2,486
Medicare Billing
$101,853
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 84 | $12,520 | $5,639 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 60 | $10,500 | $5,327 | 50.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 94 | $5,068 | $1,057 | 20.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 15 | 19 | $2,788 | $427.31 | 15.3% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 12 | 20 | $600.00 | $281.88 | 47.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 19 | 31 | $484.00 | $67.58 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 191 | $28,650 | $13,789 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 99 | $17,325 | $10,336 | 59.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 15 | 75 | $8,625 | $4,439 | 51.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 29 | 69 | $17,250 | $2,092 | 12.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 27 | 82 | $2,460 | $1,257 | 51.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 22 | 48 | $7,200 | $1,076 | 14.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 32 | 95 | $3,325 | $857.62 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 55 | $2,966 | $661.97 | 22.3% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 31 | 67 | $5,360 | $600.38 | 11.2% |
| 94016 | Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | Office | 2022 | 18 | 25 | $1,000 | $503.09 | 50.3% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 19 | 32 | $1,280 | $443.92 | 34.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 13 | 22 | $330.00 | $49.16 | 14.9% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2022 | 18 | 29 | $1,015 | $2.90 | 0.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 182 | $27,300 | $13,563 | 49.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 83 | $14,525 | $7,760 | 53.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 26 | 55 | $13,750 | $2,076 | 15.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 33 | 69 | $10,350 | $1,622 | 15.7% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 37 | 129 | $4,515 | $1,056 | 23.4% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 31 | 64 | $1,920 | $986.58 | 51.4% |
About Dr. Jose Moreno, MD
Dr. Jose Moreno, MD is a Allergy & Immunology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801820212.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Moreno, MD has received a total of $160,111 in payments from pharmaceutical and medical device companies, with $437.15 received in 2024. These payments were reported across 584 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($134,428).
As a Medicare-enrolled provider, Moreno has provided services to 933 Medicare beneficiaries, totaling 2,486 services with total Medicare billing of $101,853. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Infectious Disease
- Location Miami, FL
- Active Since 07/10/2006
- Last Updated 04/13/2015
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1801820212
Products in Payments
- AREXVY (Drug) $37,009
- TRELEGY ELLIPTA (Drug) $27,416
- CUVITRU (Biological) $24,179
- CINRYZE (Drug) $22,626
- Dymista (Drug) $17,813
- HYQVIA (Biological) $4,944
- Odactra (Drug) $1,421
- NUCALA (Biological) $1,364
- DUPIXENT (Biological) $1,145
- FASENRA (Drug) $697.06
- CUTAQUIG (Biological) $681.22
- BREO (Drug) $519.64
- TEZSPIRE (Biological) $459.21
- Xolair (Biological) $405.51
- FASENRA (Biological) $401.46
- DUPIXENT (Drug) $310.70
- ZERBAXA (Drug) $298.09
- EUCRISA (Drug) $261.07
- Epclusa (Drug) $232.35
- TAKHZYRO (Biological) $224.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Miami
Dr. Nina Ramirez, M.d, M.D
Allergy & Immunology — Payments: $874,497
Allergy & Immunology $874,497
Dr. Ileana Rodicio, Md, MD
Allergy & Immunology — Payments: $43,016
Allergy & Immunology $43,016
Dr. Neil Gershman, M.d, M.D
Allergy & Immunology — Payments: $21,986
Allergy & Immunology $21,986
Jaime Alvarez
Allergy & Immunology — Payments: $12,562
Allergy & Immunology $12,562
Mr. Jose Carpio, M.d, M.D
Allergy & Immunology — Payments: $9,872
Allergy & Immunology $9,872
Dr. Bassem Chahine, M.d, M.D
Allergy & Immunology — Payments: $7,324
Allergy & Immunology $7,324